BrunGa
Active member
Danish pharma group becomes Europe's most valuable firm after UK weight loss drug launch Danish drugmaker Novo Nordisk is now Europe's largest company in market capitalisation, ahead of French luxury giant LVMH. This follows the UK launch of Wegovy, a weight loss drug that cuts appetite and cravings. Tens of thousands of people have already signed up to waiting lists for the treatment. Also in this edition: Qantas's long-serving CEO will retire earlier than expected following a ticket scandal and we take a look at the startup bringing solar-powered cold storage to Kenyan farmers.